بررسی ارزش تشخیصی رنگ‌پذیری P504S در تشخیص کانسر پروستات
Authors
Abstract:
Background and aim: The distinction between benign and malignant prostate lesions is one of the important issues in pathology. Misdiagnosis in these cases can lead to unnecessary treatments. The purpose of this study was to evaluate the diagnostic value of P504S sputum penetration in diagnosis of prostate cancer. Material and Methods: In this experimental study, 33 benign samples and 33 prostate malignant samples from needle biopsy were selected by available sampling method and the immunohistochemical marker P504S was determined. Following the pathology diagnostic method as a standard, the immunohistochemical marker P504S of benign cases was compared to malignant ones (P<0.05). Results: Comparing the results of two methods of P504S staining and pathologic methods showed that there is a significant relationship between these two methods in the diagnosis of prostate malignancies. (P=0.0001). Also, considering the pathologic diagnosis as the standard Gold method for diagnosis of prostate malignancies, all four sensitivity, specificity, positive predictive value and negative predictive value for P504S staining method in diagnosis of prostate malignancies was 97%. Conclusion: The findings of this study showed that this coloration has high sensitivity, specificity and high predictive value in evaluating the value of diagnosis of P504S staining method in diagnosis of prostate cancer. Therefore it can be used with high confidence in the differentiation of benign prostatic malignant lesions in diagnostic laboratories.
similar resources
مارکر P504S در تشخیص پرولیفراسیون غددی آتیپیک پروستات
Background: Transrectal ultrasonography guided needle biopsy of prostate frequently used for early detection of cancer has faced the pathologists with a major diagnostic challenge. In recent years P504S has been used as a tumor cell marker for definitive diagnosis of prostatic cancer in small biopsy specimens.Methods: 70 prostate needle biopsies and 6 transurethral resections (TURP) containing ...
full textبررسی ارزش تشخیصی CA125 و HE4 در مرحله‌بندی کانسر آندومتر
Background: Endometrial carcinoma is considered the most common gynecological cancer in the world. Pelvic and para-aortic lymphadenectomy is widely advised based on FIGO staging system. The purpose of this study was to determine whether the biomarker human epididymis protein 4(HE4) correlates with depth of myometrial invasion, histologic grade and metastases in patients with endometrioid adenoc...
full textبررسی ارزش تشخیصی ca۱۲۵ و he۴ در مرحله بندی کانسر آندومتر
زمینه و هدف: سرطان آندومتر شایعترین بدخیمی دستگاه ژنیتال در زنان می باشد. استفاده از روش های تشخیصی غیرتهاجمی مانند اندازه گیری بیومارکرهای سرمی ca125 و he4 در صورتی که دقت تشخیص خوبی داشته باشند می توانند در فاز پیش از آغاز درمان جهت برنامه ریزی مناسب درمان برای بیمار به کار روند. روش بررسی: در یک مطالعه مقطعی (cross-sectional) 68 بیمار که در فاصله زمانی بین آبان 91 تا آبان 93 با نمونه پاتولوژ...
full textبررسی ارزش Diffusion Weighted Imaging در تصاویر MRI برای تشخیص سرطان پروستات
Background: Prostate cancer is the third leading cause of death and is the most common cause of cancer in elderly men. Regarding to the low accuracy of screening methods such as prostate-specific antigen (PSA), Digital Rectal Examination (DRE) and trans rectal ultrasound (TRUS) in detection and localization of tumor, Magnetic Resonance Imaging (MRI) and Diffusion Weighted Imaging (DWI) attracte...
full textارتباط وازکتومی با کانسر پروستات
در اواخر دهه 1960،روش وازکتومی شناخته شد واز آن زمان به بعد به طور گسترده ای به عنوان یکی از روشهای پیشگیری از بارداری در زوجینی که تمایل به داشتن فرزند بیشتری ندارند مورد استفاده قرارگرفته است. در کشورهای پیشرفته سرطان پروستات سومین بدخیمی شایع در مردان می باشد.درطی سالیان گذشته چندین مطالعه وجود رابطه ای را بین وازکتومی و سرطان پروستات گزارش نموده اند در حالیکه برخی از مطالعات دیگر این رابطه ...
full textMy Resources
Journal title
volume 2 issue 2
pages 0- 0
publication date 2018-09
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023